05/28/2026
📈Trials are underway from immunology portfolios across the biggest names in pharma to test whether combining different treatment targets can lead to breakthrough efficacy in Crohn’s disease and ulcerative colitis. However, questions remain about the validity of the hypothesis.
👉Visit our blog to read more about this topic: https://hubs.li/Q04h0JVP0
If you’ve got questions, NoeticInsight can help you find answers. Discuss new drug developments with an expert in the field: https://hubs.li/Q04h0PKN0